PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.\', \'Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3052, Australia.\', \'The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia. coussens.a@wehi.edu.au.\', \'Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3052, Australia. coussens.a@wehi.edu.au.\', \'Department of Pathology, Institute of Infectious Disease and Molecular Medicine, Wellcome Centre for Infectious Diseases Research in Africa, University of Cape, Cape Town, South Africa. coussens.a@wehi.edu.au.\', \'The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia. eriksson@wehi.edu.au.\', \'Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3052, Australia. eriksson@wehi.edu.au.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s10020-021-00422-z
?:doi
?:hasPublicationType
?:journal
  • Molecular medicine (Cambridge, Mass.)
is ?:pmid of
?:pmid
?:pmid
  • 34930107
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34930107>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34930107>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all